Brittany Sinclaire

618 total citations
7 papers, 10 citations indexed

About

Brittany Sinclaire is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brittany Sinclaire has authored 7 papers receiving a total of 10 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 2 papers in Pathology and Forensic Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brittany Sinclaire's work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (3 papers) and Advanced Breast Cancer Therapies (2 papers). Brittany Sinclaire is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (3 papers) and Advanced Breast Cancer Therapies (2 papers). Brittany Sinclaire collaborates with scholars based in United States. Brittany Sinclaire's co-authors include Andrew Ip, Andrew L. Pecora, Samir Gupta, Barbara Ma, Tatyana Feldman, Opeyemi A. Jegede, Lori A. Leslie, Neil J. Shah, Eric Muller and Michael B. Atkins and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Brittany Sinclaire

5 papers receiving 10 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brittany Sinclaire United States 2 9 4 3 2 1 7 10
Thomas Gevaert Belgium 2 9 1.0× 3 0.8× 3 1.0× 1 0.5× 1 1.0× 3 10
Francesca Ligori Malcolm United Kingdom 3 12 1.3× 3 0.8× 2 0.7× 5 16
Heiko Graf Switzerland 2 7 0.8× 6 1.5× 3 1.0× 3 7
Urânia Fernandes Portugal 2 8 0.9× 5 1.3× 2 0.7× 2 2.0× 8 17
A. Fernandez Ortega Spain 2 8 0.9× 3 0.8× 4 1.3× 1 1.0× 4 10
Yingni Lian China 2 9 1.0× 6 1.5× 2 0.7× 1 1.0× 3 10
Lina Zhao China 2 8 0.9× 8 2.0× 2 0.7× 2 1.0× 2 2.0× 3 13
D.A. Vorobiof United Kingdom 3 7 0.8× 5 1.3× 2 0.7× 1 0.5× 1 1.0× 6 11
Eliana Dietrich United States 2 4 0.4× 4 1.0× 4 1.3× 5 11
Alex Barrett United States 2 6 0.7× 4 1.0× 3 1.0× 2 2.0× 10 11

Countries citing papers authored by Brittany Sinclaire

Since Specialization
Citations

This map shows the geographic impact of Brittany Sinclaire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brittany Sinclaire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brittany Sinclaire more than expected).

Fields of papers citing papers by Brittany Sinclaire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brittany Sinclaire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brittany Sinclaire. The network helps show where Brittany Sinclaire may publish in the future.

Co-authorship network of co-authors of Brittany Sinclaire

This figure shows the co-authorship network connecting the top 25 collaborators of Brittany Sinclaire. A scholar is included among the top collaborators of Brittany Sinclaire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brittany Sinclaire. Brittany Sinclaire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Ahn, Jaeil, Brittany Sinclaire, Christina Cho, et al.. (2025). Real-World Outcomes of Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Third-Line Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Single-Center Study. SHILAP Revista de lepidopterología. 6(1). 3–3. 1 indexed citations
2.
Feghali, Karine A. Al, Brittany Sinclaire, Michael Marafelias, et al.. (2024). Prevalence of non-Hodgkin lymphoma patients at high-risk of failure after CAR T-cell therapy eligible for bridging radiation therapy. Frontiers in Oncology. 14. 1425506–1425506.
3.
Jegede, Opeyemi A., Brittany Sinclaire, Samir Gupta, et al.. (2023). 1418 Treatment-free survival in patients with advanced melanoma and non-small cell lung cancer receiving immune checkpoint inhibitors: real-world outcomes over a 3-year timespan. SHILAP Revista de lepidopterología. A1576–A1577. 1 indexed citations
4.
Derry, Heather M., Jaeil Ahn, Brittany Sinclaire, et al.. (2023). Associations between psychosocial risk factors and immune checkpoint inhibitor outcomes.. Journal of Clinical Oncology. 41(16_suppl). 12134–12134.
5.
Ip, Andrew, Brittany Sinclaire, Michael Marafelias, et al.. (2023). The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real‐world, multicenter, retrospective study. Cancer. 129(12). 1885–1894. 6 indexed citations
6.
Ip, Andrew, Shuo Wang, Brittany Sinclaire, et al.. (2021). Late immune-related adverse events with immune checkpoint inhibitors.. Journal of Clinical Oncology. 39(15_suppl). 2635–2635. 1 indexed citations
7.
Shah, Neil J., Shuo Wang, Aquino Williams, et al.. (2021). Real-world outcomes of treatment with immune checkpoint inhibitors in unique patient cohorts: Elderly, non-caucasian race, poor performance status, obese, chronic viral infections, and autoimmune diseases.. Journal of Clinical Oncology. 39(15_suppl). 2641–2641. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026